A survey from 2021 through 2023 for the causes of the emerging chickpea health issue was inconclusive. However, interactions of abiotic and biotic factors and the potential for sedaxane-containing seed treatments to reduce severity require further research. A chickpea health issue was first noted in July...

Two weeks after metribuzin treatment, chickpea mortality was 25% at the full label rate, and 56% for the 2X rate. Accumulated chlorosis and necrosis were similar for the control and 1/2X rate. The 1X rate significantly reduced pod production by 75% and was similar to...

Verified by MonsterInsights